0001104659-21-046732.txt : 20210405 0001104659-21-046732.hdr.sgml : 20210405 20210405201945 ACCESSION NUMBER: 0001104659-21-046732 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20210401 FILED AS OF DATE: 20210405 DATE AS OF CHANGE: 20210405 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pirzkall Andrea CENTRAL INDEX KEY: 0001818578 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-38596 FILM NUMBER: 21807713 MAIL ADDRESS: STREET 1: C/O REPLIMUNE GROUP, INC. STREET 2: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Replimune Group, Inc. CENTRAL INDEX KEY: 0001737953 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 822082553 STATE OF INCORPORATION: DE FISCAL YEAR END: 0331 BUSINESS ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: (781) 222-9600 MAIL ADDRESS: STREET 1: 500 UNICORN PARK CITY: WOBURN STATE: MA ZIP: 01801 4 1 tm2112099-13_4seq1.xml OWNERSHIP DOCUMENT X0306 4 2021-04-01 0 0001737953 Replimune Group, Inc. REPL 0001818578 Pirzkall Andrea C/O REPLIMUNE GROUP, INC. 500 UNICORN PARK WOBURN MA 01801 0 1 0 0 Chief Medical Officer Common Stock 2021-04-01 4 A 0 20500 0 A 21500 D Employee Stock Option (right to buy) 31.58 2021-04-01 4 A 0 30750 0 A 2031-04-01 Common Stock 30750 30750 D Represents shares of the Issuer's common stock issuable upon settlement of restricted stock units ("RSUs") granted to the Reporting Person. Each RSU represents a contingent right to receive one share of the Issuer's common stock. 25% of the RSUs will vest on May 15, 2022 and the remainder will vest in three approximately equal annual installments thereafter until May 15, 2025, subject to the Reporting Person's continuous service to the Issuer. 1,000 shares of the Issuer's common stock are held by the Reporting Person's husband. The Reporting Person may be deemed to be the beneficial owner of such shares. 25% of the shares underlying this stock option vest on April 1, 2022, and the remainder of the shares underlying this stock option vest in 36 approximately equal monthly installments thereafter. /s/ Jean Franchi, attorney-in-fact 2021-04-05